Comment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study].
作者信息
Kamal Shahed, Segal Jonathan P
机构信息
Department of Gastroenterology, Northern Health, 185 Cooper Street, Epping, Melbourne, VIC 3076, Australia.
Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Melbourne, VIC, Australia.
出版信息
Therap Adv Gastroenterol. 2024 Jul 23;17:17562848241265761. doi: 10.1177/17562848241265761. eCollection 2024.
Abstract
摘要
相似文献
1
Comment on: [10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study].
Therap Adv Gastroenterol. 2024 Jul 23;17:17562848241265761. doi: 10.1177/17562848241265761. eCollection 2024.
2
10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study.
Therap Adv Gastroenterol. 2023 Sep 29;16:17562848231201728. doi: 10.1177/17562848231201728. eCollection 2023.
3
Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Dig Dis Sci. 2020 May;65(5):1436-1444. doi: 10.1007/s10620-019-05867-1. Epub 2019 Nov 1.
4
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
Inflamm Bowel Dis. 2019 Jul 17;25(8):1417-1427. doi: 10.1093/ibd/izz001.
5
Real-world evidence on adherence, persistence, switching and dose escalation with biologics in adult inflammatory bowel disease in the United States: A systematic review.
J Clin Pharm Ther. 2019 Aug;44(4):495-507. doi: 10.1111/jcpt.12830. Epub 2019 Mar 14.
6
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.
BMC Gastroenterol. 2022 Dec 29;22(1):545. doi: 10.1186/s12876-022-02560-y.
7
Comparison of Biologic Disease-Modifying Antirheumatic Drug Therapy Persistence Between Biologics Among Rheumatoid Arthritis Patients Switching from Another Biologic.
Rheumatol Ther. 2015 Jun;2(1):59-71. doi: 10.1007/s40744-014-0006-3. Epub 2014 Dec 23.
8
Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Rheumatol Int. 2016 Jan;36(1):143-53. doi: 10.1007/s00296-015-3348-4. Epub 2015 Aug 28.
9
Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.
Clin Rheumatol. 2017 May;36(5):1013-1022. doi: 10.1007/s10067-017-3584-y. Epub 2017 Feb 27.
10
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
J Crohns Colitis. 2024 Jun 3;18(6):790-800. doi: 10.1093/ecco-jcc/jjad203.
本文引用的文献
1
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.
Dig Dis Sci. 2024 May;69(5):1808-1825. doi: 10.1007/s10620-023-08252-1. Epub 2024 Mar 18.
2
10 years of biologic use patterns in patients with inflammatory bowel disease: treatment persistence, switching and dose intensification - a nationwide population-based study.
Therap Adv Gastroenterol. 2023 Sep 29;16:17562848231201728. doi: 10.1177/17562848231201728. eCollection 2023.
3
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2.
4
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725.
Zotero 插件